About Escare Formulations Private Limited
Data last updated:
Escare Formulations Private Limited is a private limited company based in Kalyan West, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 June 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH1997PTC108783. Its GSTIN is 08AABCE4303L1ZS (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Kumar Garg and Babita Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 2 A Wing Vastu Sidhi Yogi Dham, Kalyan West, Maharashtra, India – 421301.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.29 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹2.04 Lakh (net margin 1.6%) and EBITDA of ₹3.55 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website escare.co.in.
Company details
Contact details
Escare Formulations Private Limited's registered office is in Kalyan West, Maharashtra. Its website is escare.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 2 A Wing Vastu Sidhi Yogi Dham, Kalyan West, Maharashtra, India – 421301
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Escare Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Escare Formulations is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Escare Formulations Private Limited, buy the company report.
Financials of Escare Formulations Private Limited
FY 2025 filings availableEscare Formulations Private Limited reported revenue of ₹1.29 Cr (up 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 43% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Escare Formulations Private Limited, buy the company report.
Board of directors of Escare Formulations Private Limited
Escare Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar Garg | Director | 16 Jun 1997 | 29 Years 4 Months | Current |
| Babita Garg | Director | 16 Jun 1997 | 29 Years 4 Months | Current |
Auditor
Escare Formulations Private Limited is audited by S SINGHAL & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S SINGHAL & CO | FY 2020 | 001526C |
Shareholding
The shareholding of Escare Formulations Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Escare Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Oct 2019 | 100295910 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Escare Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Escare Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Escare Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AABCE4303L1ZS | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Escare Formulations Private Limited, buy the company report.
Recent activity
Escare Formulations Private Limited has 2 board changes on record since 1997: 2 appointments. The latest: Babita Garg was appointed as Director on 16 Jun 1997.
Frequently asked questions
Escare Formulations is an active private limited company based in Kalyan West, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 June 1997 (29+ years old) and is registered under CIN U51900MH1997PTC108783.
Escare Formulations has 2 current directors:
- Sanjay Kumar Garg - Director
- Babita Garg - Director
The latest financial statements of Escare Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Escare Formulations is 08AABCE4303L1ZS, registered in Rajasthan.
The CIN (Corporate Identification Number) of Escare Formulations is U51900MH1997PTC108783. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Escare Formulations was incorporated on 16 June 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.
Babita Garg was appointed as Director on 16 Jun 1997. Sanjay Kumar Garg was appointed as Director on 16 Jun 1997.
Escare Formulations can be reached through the website escare.co.in. Its registered office is in Kalyan West, Maharashtra, India.
The registered office of Escare Formulations is at Office No. 2 A Wing Vastu Sidhi Yogi Dham, Kalyan West, Maharashtra, India – 421301.
Escare Formulations operates in the pharma industry, in the drug formulation and development segment.